PPCB Key Statistics, Chart & Performance
The current stock price of PPCB is 0.22 USD. In the past month the price decreased by -59.41%.
PPCB Technical Analysis
PPCB Financial Highlights
Over the last trailing twelve months PPCB reported a non-GAAP Earnings per Share(EPS) of -703.62. The EPS increased by 98.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2147.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PPCB Forecast & Estimates
PPCB Ownership
PPCB Latest News, Press Relases and Analysis
PPCB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.54 | 398.827B | ||
| AMGN | AMGEN INC | 15.03 | 182.324B | ||
| GILD | GILEAD SCIENCES INC | 16.04 | 177.765B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.87 | 118.135B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.34 | 79.79B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 49.12 | 46.476B | ||
| INSM | INSMED INC | N/A | 33.518B | ||
| NTRA | NATERA INC | N/A | 31.422B | ||
| BIIB | BIOGEN INC | 11.44 | 25.931B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.23 | 20.594B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PPCB
Company Profile
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.
Company Info
PROPANC BIOPHARMA INC
302/6 Butler Street, Camberwell
Melbourne VICTORIA AU
Employees: 1
Phone: 61398820780
PROPANC BIOPHARMA INC / PPCB FAQ
Can you describe the business of PROPANC BIOPHARMA INC?
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.
What is the stock price of PROPANC BIOPHARMA INC today?
The current stock price of PPCB is 0.22 USD. The price decreased by -3.89% in the last trading session.
Does PROPANC BIOPHARMA INC pay dividends?
PPCB does not pay a dividend.
How is the ChartMill rating for PROPANC BIOPHARMA INC?
PPCB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists PPCB stock?
PPCB stock is listed on the Nasdaq exchange.
What is the ownership structure of PROPANC BIOPHARMA INC (PPCB)?
You can find the ownership structure of PROPANC BIOPHARMA INC (PPCB) on the Ownership tab.